Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

IgLON5 antibodies are infrequent in patients with isolated sleep apnea

K. Hasselbacher, A. Steffen, K. P. Wandinger, N. Brüggemann*

*Korrespondierende/r Autor/-in für diese Arbeit
OriginalspracheEnglisch
ZeitschriftEuropean Journal of Neurology
Jahrgang25
Ausgabenummer4
Seiten (von - bis)e46-e47
ISSN1351-5101
DOIs
PublikationsstatusVeröffentlicht - 01.04.2018

Fördermittel

All participants are gratefully thanked for their invaluable participation. Dr Hassel-bacher has received personal fees and travel expenses from Inspire Medical Systems. Dr Steffen has received reimbursement of conference fees and travel and accommodation expenses, fees for preparing scientific continuing professional development or other events, funding for research he himself initiated, and fees for conducting clinical studies on related subjects from Inspire Medical Systems, Merz and Resmed. Dr Wandinger has nothing to declare. Dr Bru€ggemann was funded by the Collaborative Center for X-linked Dystonia-Parkinsonism and the German Research Foundation (BR 4328/2-1) and received speakers’ honoraria from the German Neurological Society. He received travel grants from Merz and St Jude Medical and a honorarium from Grünenthal.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 10 – Weniger Ungleichheiten
    SDG 10 – Weniger Ungleichheiten

Strategische Forschungsbereiche und Zentren

  • Querschnittsbereich: Medizinische Genetik

Zitieren